# Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization

Study · id `cardio:ct-nct02961894` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02961894](<https://clinicaltrials.gov/study/NCT02961894>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02961894

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

## Technical summary

Registry record NCT02961894. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-07 (actual); primary completion 2019-02-28 (actual). Results posted on 2020-11-02.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 121 participants (enrolled count; ClinicalTrials.gov record NCT02961894, source copy `cardio:ctgov-nct02961894-2020-11-02`, retrieved 2026-10-31)
- Started: 2017-06-07 (actual) (ClinicalTrials.gov record NCT02961894, source copy `cardio:ctgov-nct02961894-2020-11-02`, retrieved 2026-10-31)
- Primary completion: 2019-02-28 (actual) (ClinicalTrials.gov record NCT02961894, source copy `cardio:ctgov-nct02961894-2020-11-02`, retrieved 2026-10-31)
- Completion: 2019-09-20 (actual) (ClinicalTrials.gov record NCT02961894, source copy `cardio:ctgov-nct02961894-2020-11-02`, retrieved 2026-10-31)
- Results first posted: 2020-11-02 (ClinicalTrials.gov record NCT02961894, source copy `cardio:ctgov-nct02961894-2020-11-02`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT02961894, source copy `cardio:ctgov-nct02961894-2020-11-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02961894-2020-11-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization
- Acronym: REVEAL
- Condition: Peripheral Artery Disease
- Intervention (Device): Revolution™ Peripheral Atherectomy System
- Lead sponsor: Rex Medical
- Lead sponsor class: INDUSTRY
- Collaborator: Syntactx
- Collaborator class: NETWORK

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as a collaborator: Syntactx (`cardio:org-syntactx`)

## Provenance

Content hash: 7e96dac2f117af40a53ea85d65a73cfd673516f25a7ab540dfbbeab1e62ecc30
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
